LABORATORIOS FARMACEUTOCOS ROVI SA EUR0.06 financial statements, including revenue, expenses, and profit
The total revenue of 0ILL for the last quarter is 199.14 M EUR, and it's 15.36% lower compared to the previous quarter. The net income of Q4 24 is 23.39 M EUR.